29 October 2019

etc.venues, Prospero House 241 Borough High Street, London, SE1 1GA

Final Agenda

The meeting will start promptly at 10:00 and is expected to finish at approximately 13:00.

Please note that this agenda is a final and is subject to change before the meeting.

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Apologies – Part 1 only (open session)
  3. Any other business – Part 1 only (open session)
  4. Appraisal of patiromer for treating hyperkalaemia [ID877]
    • 4.1. Declarations of interest – Part 1 only (open session)
    • 4.2. Introduction by Chair, Dr Amanda Adler – Part 1 only (open session)
    • 4.3. Presentation by the Chair, Dr Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 4.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  5. Appraisal of cladribine tablets for treating relapsing–remitting multiple sclerosis (Update of TA493) [ID2703]
    5.1. Declarations of interest – Part 2 only (closed session)
    5.2. Introduction by Vice-Chair, Dr Sanjeev Patel  Part 2 only (closed session)
    5.3. Presentation by the Vice-Chair, Dr Sanjeev Patel  Part 2 only (closed session)
    5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session) 

  6. Appraisal of cannabidiol for adjuvant treatment of seizures associated with Dravet syndrome [ID1211]
    • 6.1. Declarations of interest – Part 2 only (closed session)
    • 6.2. Introduction by Chair, Dr Amanda Adler – Part 2 only (closed session)
    • 6.3. Presentation by the Chair, Dr Amanda Adler – Part 2 only (closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  7. Appraisal of cannabidiol for adjuvant treatment of seizures associated with Lennox-Gastaut syndrome [ID1308]
    • 7.1. Declarations of interest – Part 2 only (closed session)
    • 7.2. Introduction by Chair, Dr Amanda Adler – Part 2 only (closed session)
    • 7.3. Presentation by the Chair, Dr Amanda Adler – Part 2 only ( closed session)
    • 7.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

    To print an agenda, please right click and select 'Print' from the menu.

Date, time and venue of next meeting

The next meeting will take place on Tuesday 26 November 2019, 10:00 venue: National Institute for Health and Care Excellence, 10 Spring Gardens, London, SW1A 2BU.

Please note all timings are approximate.

How to register

  • Click on the register link below and complete the registration form, selecting the topics you would like to attend.
  • You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
  • Registration will close on Friday 18 October 2019Please note that it may not be possible to accept late requests. 
  • Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Rosalee Mason.
  • Registrants wishing to conduct a research study on committee meetings and/or NICE processes will require prior permission. Contact the NICE Enquiry Handling team at nice@nice.org.uk.
  • Further information about conducting research is also available in our common questions and answers about meetings in public document.

 

Registration period: 04 to 18 October 2019
Registration is closed.